News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Wockhardt Gets Tentative FDA Approval For Generic Alzheimer Treatment



4/25/2011 7:05:32 AM

WSJ -- Wockhardt Ltd. (532300.BY) Monday said it has received tentative approval from the U.S. Food & Drug Administration to sell a generic version of Eisai Co.'s (4523.TO) Aricept, a drug for treating Alzheimer's disease. Tentative approval by the FDA means that, although a product meets all safety, efficacy and manufacturing quality standards required for it to be sold in the U.S., existing patents, or proprietary issues, currently prevent sales. Wockhardt won't be able to sell its version until it receives final approval from the FDA.

Read at Wall Street Journal
Read at RTT News
Read at PharmaBiz
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES